ArticleMalaria journal2025
Trends of malaria incidence, prevalence, mortality, and disability-adjusted life years in Eastern Africa region from 1990 to 2021: a systematic analysis from Global Burden of Disease 2021 study.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Determinants of Delayed Malaria Treatment-Seeking Among Under-Five Children in a Post-Conflict District of Northern Ethiopia: A Facility-Based Unmatched Case-Control Study.Journal of epidemiology and global health · 2026Article
- Malaria in the 21st Century: Global Disease Burden, Epidemiological Insights, and Strategic Control Approaches.Biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria has long been a global health priority, particularly in Eastern Africa, where it remains the leading cause of child mortality and a significant barrier to socioeconomic development. Despite extensive control efforts, ineffective programs, limited treatment access, and low distribution of artemisinin-based combination therapy, contribute to the persistent challenges. Understanding malaria trends is crucial for evidence-based prevention and control strategies. The objective of the study was to estimate the trend in malaria incidence, prevalence, mortality, and Disability-Adjusted Life Years (DALYs) in Eastern Africa Region, from 1990 to 2021.
methodsThis study is part of the 2021 Global Burden of Disease Study. The burden of malaria was assessed using age-standardized incidence, prevalence, mortality, and DALY rates, stratified by age, sex, and countries. Annual and total percentage changes were calculated to evaluate Long-term trends. Line graphs were used to compare disease burden by age and gender over time.
resultsMalaria incidence, mortality, prevalence and DALYs declined significantly in Eastern Africa region from 1990 to 2021. The rate of incidence, prevalence, mortality and DALYs of malaria in Eastern Africa decreased by 54%, 61.8%, 62%, and 63.8%, respectively. However malaria burden remained highest among children under five, with DALYs peaking in neonates aged 7-27 days. In 2021, South Sudan had the highest age-standardized incidence and prevalence rate whereas Uganda recorded the highest malaria mortality and DALY rate. The Comoros showed significant declined in malaria burden, whereas Ethiopia experienced an increases in all metrics from 1990 and 2021. Child underweight and stunting were the major risk factors for malaria-related DALYs and deaths in 2021.
conclusionsDespite overall progress, malaria remains a major health threat in Eastern Africa nations, with the three leading countries in the region being South Sudan, Ethiopia and Uganda. The highest disease burden persists among neonates aged 7-27 days, underscoring the urgent need for targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.